|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3600 SEK | +1.69% |
|
-.--% | - |
| 06-04 | Spotlight moves Pharmalundensis shares to observation list | FW |
| 05-28 | Pharmalundensis reports widened operating loss, targets mid-July delisting | FW |
| Market Cap | 23.14M 2.42M 2.11M 1.94M 1.83M 3.42M 228M 3.45M 8.99M 112M 9.09M 8.89M 390M | P/E 2024 |
-5.02x | P/E 2025 | -3.04x |
|---|---|---|---|---|---|
| Enterprise Value | 26.7M 2.79M 2.43M 2.24M 2.11M 3.95M 263M 3.98M 10.37M 130M 10.49M 10.26M 450M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.69% |
| 3 years | 0.16 |  | 1.51 |
| 5 years | 0.16 | | 2.4 |
| 10 years | 0.16 | | 11.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Staffan Skogvall
CEO | Chief Executive Officer | 63 | 2005-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Staffan Skogvall
BRD | Director/Board Member | 63 | 2005-12-31 |
Arne Skogvall
CHM | Chairman | 94 | - |
Bo Wennergren
BRD | Director/Board Member | 75 | - |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.63M -380K -331K -305K -287K -536K -35.77M -540K -1.41M -17.63M -1.42M -1.39M -61.1M | -7.11M -744K -648K -597K -562K -1.05M -70.08M -1.06M -2.76M -34.54M -2.79M -2.73M -120M |
| Net Debt | 3.87M 405K 353K 325K 306K 573K 38.19M 577K 1.5M 18.82M 1.52M 1.49M 65.23M | 3.56M 372K 324K 299K 281K 526K 35.09M 530K 1.38M 17.29M 1.4M 1.37M 59.93M |
Employees
2
Sector
-
- Stock Market
- Stocks
- PHAL Stock
Select your edition
All financial news and data tailored to specific country editions
